The Effects of Conventional Therapy on Tinnitus, Disability, and Quality of Life in Patients With Tinnitus
Starting soon · Not applicable
Conditions studied: Tinnitus, Neural Therapy of Huneke
In brief
A randomized, single-blind, controlled trial to evaluate the effects of neural therapy on tinnitus severity, disability, and quality of life in patients with tinnitus. The study is planned to be conducted between December 2025 and March 2026. The sample size is 30 patients. The number of centers is 1. The study duration is 3 months.
Key facts
- Study ID
- NCT07334002
- Run by
- Sisli Hamidiye Etfal Training and Research Hospital
- People needed
- 30
- Starts
- 2026-03-01
- Expected to finish
- 2026-05-26
- Last updated by the study team
- 2026-03-23
Who can join
Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients with a type A tympanogram in the tympanogram of all cases with normal otological examinations (air-bone gap should not be observed in any case).
You may not qualify if…
- Patients with a disease that may cause objective tinnitus,
- Otosclerosis,
- Chronic otitis media,
- Acoustic tumor,
- Meniere's disease,
- History of ear surgery or head trauma, and those with neuropsychiatric diseases.
- Also:
- Patients who have had ear surgery,
- Permanent hearing loss (total),
- Severe cardiovascular system failure, uncontrolled arrhythmia,
- Severe renal failure, or liver failure
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.